Boardman, Dominic A.
Levings, Megan K.
Article History
First Online: 18 February 2019
Competing interests
: M.K.L. has received research funding from TxCell, Pfizer and Bristol Myers Squibb, and has patents pending on alloantigen-specific chimaeric antigen receptors.